Logo GE HealthCare

GE HealthCare (GEHC) stock: analyst price target and their real reliability

Live quote · data updated Oct 14, 2026
GE HealthCare · Health Care · ref. ETF XLV · 50 calls · price $68.79
💬JPI AI AssistantTry it →
What the company does: GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.

📈 GE HealthCare (GEHC) stock price

$68.79-4.9% over range
Oct 14, 25low $59.49 · high $88.16Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
54% recommend buying · 13 analysts
📊 JPI status : GE HealthCare has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 GEHC price target & analyst consensus — price $68.79

The price target · all analysts combined (13 targets)
Highest target · 1 firm of 13$93+35.2%
Median target · of 13 targets$77.5+12.7%
Lowest target · 1 firm of 13$65-5.5%
Current price$68.79
Where these 13 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 1077% $70 ↔ $93
Below 323% $14 ↔ $65
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Citigroup — 67% of its targets hit on this sector (516 calls tested). It aims for $71 (+3.2 %), call made on October 6, 2026, maturing on October 6, 2027 (8 d ago).

The 7 reliable analysts $84+22 %
The 6 other firms $67.50-1.9 %
How to read it: the 7 reliable firms are not filtered by optimism — 7 aim above the price, 0 below, hence their $84 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 13 ratings (last 6 months)
Strong Buy00%
Buy754%
Hold646%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about GE HealthCare? The JPI assistant answers using our backtest data.

💰 GE HealthCare dividend: yield, history & growth › open the full page

0.22%annual yield
That's ~$0.14 per share per year.

📈 GE HealthCare fundamentals: valuation, margins & growth › open the full page

P/E 15.8Net margin 9.3 %Revenue growth +5.8 %Cheap for the growth

Revenue, net income and margin per year

Revenue Net income · hover a bar for details
2022
marg. 10 %
2023
Rev +7%Profit −18%
2024
Rev +1%Profit +27%
2025
Rev +5%Profit +5%

🏛️ GE HealthCare insider buying: who's buying and how much › open the full page

6 insiders bought6 buys / 6 mo $6.1M👥 Cluster buy

🔎 Detailed analyses

✅ Historical analyst reliability on GEHC

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm ↕ % right i ↕ Gain vs sector i ↕ Calls i ↕
UBS ↗ 50% +2.3% 2
Piper Sandler ↗ 50% +0.8% 2
Mizuho ↗ 50% -0.9% 6
Wells Fargo ↗ 25% -4.8% 4
Evercore ISI Group ↗ 25% -9.0% 4
Citigroup ↗ 17% -5.7% 6
BTIG ↗ 0% -10.3% 2
Goldman Sachs ↗ 0% -14.3% 2
Stifel ↗ 0% -17.1% 2

📊 What $1,000 invested in GE HealthCare would be worth › open the full page

In short — $1,000 invested in GE HealthCare 10 years ago would be worth $1,128 today, i.e. +3%/yr on average. Best year: 2023 (+32%), worst: 2025 (+3%). Price performance, excluding dividends.

If I'd invested $1,000 in GE HealthCare

InvestmentWorth todayGain
1 years ago$795-21%
3 years ago$1,096+10%
→ See GE HealthCare's full return history + gain calculator

Return by year (GE HealthCare)

YearReturn$1,000 invested at year start
2026 (YTD)-23%$773 (-23%)
2025+3%$795 (-21%)
2024+4%$828 (-17%)
→ See GE HealthCare's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on GE HealthCare

Loading news…

📋 All analyst calls on GEHC

BTIG ↗
Oct 12, 26
▲ Buy · 🎯$75
Price at call : $67.74 — upside +11%
Today : $68.79 — upside +9%
🎯 on GEHC : 0% (1 call matured) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Oct 12, 27
Barclays ↗
Oct 7, 26
▲ Overweight · 🎯$85
Price at call : $64.67 — upside +31%
Today : $68.79 — upside +24%
🎯 on GEHC : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 7, 27
Citigroup ↗
Oct 5, 26
■ Neutral neutral · not a buy · 🎯$71
Price at call : $64.77 — gap to target +10%
Today : $68.79 — gap to target +3%
🎯 on GEHC : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Oct 5, 27
Needham ↗
Oct 5, 26
▲ Buy · 🎯$93
Price at call : $64.77 — upside +44%
Today : $68.79 — upside +35%
🎯 on GEHC : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Oct 5, 27
Needham ↗
Sep 22, 26
▲ Buy · 🎯$93
Price at call : $66.27 — upside +40%
Today : $68.79 — upside +35%
🎯 on GEHC : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Sep 22, 27
BTIG ↗
Sep 17, 26
▲ Buy · 🎯$79
Price at call : $64.44 — upside +23%
Today : $68.79 — upside +15%
🎯 on GEHC : 0% (1 call matured) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Sep 17, 27
BTIG ↗
Aug 19, 26
▲ Buy · 🎯$79
Price at call : $74.62 — upside +6%
Today : $68.79 — upside +15%
🎯 on GEHC : 0% (1 call matured) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Aug 19, 27
UBS ↗
Jul 31, 26
■ Neutral neutral · not a buy · 🎯$73
Price at call : $69.73 — gap to target +5%
Today : $68.79 — gap to target +6%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jul 31, 27
See the other 42 calls, newest to oldest
Citigroup ↗
Jul 30, 26
■ Neutral neutral · not a buy · 🎯$75
Price at call : $68.02 — gap to target +10%
Today : $68.79 — gap to target +9%
🎯 on GEHC : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Jul 30, 27
▲ Outperform · 🎯$84
Price at call : $68.02 — upside +23%
Today : $68.79 — upside +22%
🎯 on GEHC : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jul 30, 27
Wells Fargo ↗
Jul 30, 26
▲ Overweight · 🎯$85
Price at call : $68.02 — upside +25%
Today : $68.79 — upside +24%
🎯 on GEHC : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jul 30, 27
BTIG ↗
Jul 29, 26
▲ Buy · 🎯$79
Price at call : $69.94 — upside +13%
Today : $68.79 — upside +15%
🎯 on GEHC : 0% (1 call matured) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Jul 29, 27
Hovde Group
Jul 17, 26
■ Market Perform neutral · not a buy · 🎯$14
Price at call : $62.83 — gap to target -78%
Today : $68.79 — gap to target -80%
🎯 on GEHC : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jul 17, 27
UBS ↗
Jul 16, 26
■ Neutral neutral · not a buy · 🎯$67
Price at call : $63.07 — gap to target +6%
Today : $68.79 — gap to target -3%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jul 16, 27
BMO Capital ↗
Jul 9, 26
■ Market Perform neutral · not a buy · 🎯$70
Price at call : $64.7 — gap to target +8%
Today : $68.79 — gap to target +2%
🎯 on GEHC : no call matured yet · 📊 on Health : 60.4% · +8.8% (240 calls)
in progress (365j)
matures : Jul 9, 27
RBC Capital ↗
Jun 23, 26
▲ Outperform · 🎯$80
Price at call : $64.88 — upside +23%
Today : $68.79 — upside +16%
🎯 on GEHC : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Jun 23, 27
UBS ↗
May 21, 26
■ Neutral neutral · not a buy · 🎯$69
Price at call : $64.23 — gap to target +7%
Today : $68.79 — gap to target +0%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : May 21, 27
JP Morgan ↗
May 1, 26
■ Neutral neutral · not a buy · 🎯$65
Price at call : $61.03 — gap to target +7%
Today : $68.79 — gap to target -6%
🎯 on GEHC : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : May 1, 27
Citigroup ↗
Apr 30, 26
■ Neutral neutral · not a buy · 🎯$65
Price at call : $61.03 — gap to target +7%
Today : $68.79 — gap to target -6%
🎯 on GEHC : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Apr 30, 27
Goldman Sachs ↗
Apr 30, 26
■ Neutral neutral · not a buy · 🎯$65
Price at call : $61.03 — gap to target +7%
Today : $68.79 — gap to target -6%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Apr 30, 27
Barclays ↗
Apr 30, 26
■ Equal-Weight neutral · not a buy · 🎯$78
Price at call : $61.03 — gap to target +28%
Today : $68.79 — gap to target +13%
🎯 on GEHC : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Apr 30, 27
▲ Outperform · 🎯$80
Price at call : $61.03 — upside +31%
Today : $68.79 — upside +16%
🎯 on GEHC : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Apr 30, 27
Wells Fargo ↗
Apr 30, 26
▲ Overweight · 🎯$75
Price at call : $60.84 — upside +23%
Today : $68.79 — upside +9%
🎯 on GEHC : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Apr 30, 27
BTIG ↗
Apr 29, 26
▲ Buy · 🎯$80
Price at call : $60.84 — upside +31%
Today : $68.79 — upside +16%
🎯 on GEHC : 0% (1 call matured) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Apr 29, 27
BTIG ↗
Apr 21, 26
▲ Buy · 🎯$85
Price at call : $72.26 — upside +18%
Today : $68.79 — upside +24%
🎯 on GEHC : 0% (1 call matured) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Apr 21, 27
Piper Sandler ↗
Apr 17, 26
▲ Overweight · 🎯$88
Price at call : $74.15 — upside +19%
Today : $68.79 — upside +28%
🎯 on GEHC : no call matured yet · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Apr 17, 27
Mizuho ↗
Apr 13, 26
▲ Outperform · 🎯$90
Price at call : $74.67 — upside +21%
Today : $68.79 — upside +31%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Apr 13, 27
Goldman Sachs ↗
Apr 9, 26
▲ Buy · 🎯$81
Price at call : $73.18 — upside +11%
Today : $68.79 — upside +18%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Apr 9, 27
▲ Outperform · 🎯$85
Price at call : $69.73 — upside +22%
Today : $68.79 — upside +24%
🎯 on GEHC : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Apr 6, 27
BTIG ↗
Mar 19, 26
▲ Buy · 🎯$91
Price at call : $70.38 — upside +29%
Today : $68.79 — upside +32%
🎯 on GEHC : 0% (1 call matured) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Mar 19, 27
Citigroup ↗
Mar 11, 26
■ Neutral neutral · not a buy · 🎯$84
Price at call : $70.33 — gap to target +19%
Today : $68.79 — gap to target +22%
🎯 on GEHC : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Mar 11, 27
BTIG ↗
Feb 9, 26
▲ Buy · 🎯$91
Price at call : $79.08 — upside +15%
Today : $68.79 — upside +32%
🎯 on GEHC : 0% (1 call matured) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Feb 9, 27
Barclays ↗
Feb 6, 26
■ Equal-Weight neutral · not a buy · 🎯$87
Price at call : $79.08 — gap to target +10%
Today : $68.79 — gap to target +26%
🎯 on GEHC : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Feb 6, 27
Stifel ↗
Feb 5, 26
▲ Buy · 🎯$98
Price at call : $80.65 — upside +22%
Today : $68.79 — upside +42%
🎯 on GEHC : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Feb 5, 27
▲ Outperform · 🎯$98
Price at call : $80.65 — upside +22%
Today : $68.79 — upside +42%
🎯 on GEHC : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Feb 5, 27
Wells Fargo ↗
Feb 5, 26
▲ Overweight · 🎯$97
Price at call : $82.31 — upside +18%
Today : $68.79 — upside +41%
🎯 on GEHC : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Feb 5, 27
■ Equal-Weight neutral · not a buy · 🎯$85
Price at call : $82.31 — gap to target +3%
Today : $68.79 — gap to target +24%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Feb 5, 27
BTIG ↗
Feb 4, 26
▲ Buy · 🎯$91
Price at call : $82.31 — upside +11%
Today : $68.79 — upside +32%
🎯 on GEHC : 0% (1 call matured) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Feb 4, 27
Piper Sandler ↗
Jan 30, 26
▲ Overweight · 🎯$94
Price at call : $80.11 — upside +17%
Today : $68.79 — upside +37%
🎯 on GEHC : no call matured yet · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Jan 30, 27
UBS ↗
Jan 15, 26
▼ Sell · 🎯$77
Price at call : $81.75 — upside -6%
Today : $68.79 — upside +12%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jan 15, 27
Stifel ↗
Jan 7, 26
▲ Buy · 🎯$95
Price at call : $85.76 — upside +11%
Today : $68.79 — upside +38%
🎯 on GEHC : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Jan 7, 27
■ Neutral neutral · not a buy · 🎯$92
Price at call : $85.04 — gap to target +8%
Today : $68.79 — gap to target +34%
🎯 on GEHC : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Jan 5, 27
Citigroup ↗
Dec 11, 25
■ Neutral neutral · not a buy · 🎯$88
Price at call : $83.96 — gap to target +5%
Today : $68.79 — gap to target +28%
🎯 on GEHC : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Dec 11, 26
Jefferies ↗
Dec 11, 25
▲ Buy · 🎯$105
Price at call : $83.96 — upside +25%
Today : $68.79 — upside +53%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.2% · +4.7% (383 calls)
in progress (365j)
matures : Dec 11, 26
BTIG ↗
Nov 21, 25
▲ Buy · 🎯$87
Price at call : $76.45 — upside +14%
Today : $68.79 — upside +26%
🎯 on GEHC : 0% (1 call matured) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Nov 21, 26
Morgan Stanley ↗
Oct 30, 25
■ Equal-Weight neutral · not a buy · 🎯$80
Price at call : $74.95 — gap to target +7%
Today : $68.79 — gap to target +16%
🎯 on GEHC : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Oct 30, 26
▲ Outperform · 🎯$92
Price at call : $74.95 — upside +23%
Today : $68.79 — upside +34%
🎯 on GEHC : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Oct 30, 26
Wells Fargo ↗
Oct 30, 25
▲ Overweight · 🎯$87
Price at call : $74.95 — upside +16%
Today : $68.79 — upside +26%
🎯 on GEHC : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Oct 30, 26
BTIG ↗
Oct 13, 25
▲ Buy · 🎯$89
Price at call : $71.84 — upside +24%
Today : $68.79 — upside +29%
Expected +24% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on GEHC : 0% (1 call matured) · 📊 on Health : 51.2% · +5.3% (123 calls)
-4.3%
stock -4% · XLV +20%
matured Oct 13, 26
Barclays ↗
Oct 13, 25
■ Equal-Weight neutral · not a buy · 🎯$86
Price at call : $71.84 — gap to target +20%
Today : $68.79 — gap to target +25%
🎯 on GEHC : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 13, 26

Frequently asked questions

Should I buy GE HealthCare stock?

This isn't buy advice. For GE HealthCare, the analyst consensus is "Buy", with an average price target of $77.50 (+13% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 50% of the time (2 calls tracked on GE HealthCare). We show the numbers — you decide.

Is it too late to buy GE HealthCare? How high can it go?

The most bullish analyst target on GE HealthCare is $93.00 (+35% above today's price); the average is $77.50. That's the upside they see. Check how reliable those analysts have actually been on GE HealthCare on our site before trusting it.

Is GE HealthCare still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 9 analysts have a real record on GE HealthCare, the best hitting 50% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.

Should you invest in GE HealthCare? The case for and against

The arguments for and against, one by one, from the numbers: why invest in GEHC (and why hesitate).

What has GE HealthCare's past performance been?

Historical returns and a "how much if I had invested" calculator: GEHC performance & returns.

Does GE HealthCare pay a dividend?

Yield, consistency and growth history of the dividend: GEHC's dividend.

Are insiders buying GEHC stock?

Executives' and large holders' buys and sells, decoded: insider buying on GEHC.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)